Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction

Heart

Volumn 98, Issue 7, 2012, Pages 558-565

  Potocki, Mihael ^a   Reichlin, Tobias ^a,b   Thalmann, Simone ^a   Zellweger, Christa ^a   Twerenbold, Raphael ^a   Reiter, Miriam ^a   Steuer, Stephan ^c   Bassetti, Stefano ^d   Drexler, Beatrice ^a   Stelzig, Claudia ^a   Freese, Michael ^a   Winkler, Katrin ^e,f   Haaf, Philip ^a   Balmelli, Cathrin ^a   Hochholzer, Willibald ^a   Osswald, Stefan ^a   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Emergency Department   (Switzerland)

^d Kantonsspital Olten ^*  (Switzerland)

^e INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^f HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC TROPONIN T; COPEPTIN; HIGH SENSITIVITY CARDIAC TROPONIN T; TROPONIN T; UNCLASSIFIED DRUG; VASOPRESSIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLYCOPEPTIDES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SURVIVAL RATE; TROPONIN T;

EID: 84858618064     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-301269     Document Type: Article

References (38)

1. Roger VL, Go AS, Lloyd-Jones DM, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011;123:e18-209.
2. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007;116:e148-304.
3. Bassand JP, Hamm CW, Ardissino D, et al Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-660.
4. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/ non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835-42. (Pubitemid 30643610)
5. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000;102:2031-7.
6. Tiemann O. Variations in hospitalisation costs for acute myocardial infarction - a comparison across Europe. Health Econ 2008;17(1 Suppl):S33-45. (Pubitemid 351227990)
7. Apple FS, Jesse RL, Newby LK, et al National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007;115:e352-5. (Pubitemid 46648623)
8. Apple FS, Smith SW, Pearce LA, et al. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008;54:723-8. (Pubitemid 351573705)
9. Melanson SE, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007;128:282-6. (Pubitemid 47262627)
10. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
11. Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
12. Khan SQ, Dhillon OS, O'Brien RJ, et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 2007;115:2103-10. (Pubitemid 46659061)
13. Reichlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009;54:60-8.
14. Keller T, Tzikas S, Zeller T, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010;55:2096-106.
15. Narayan H, Dhillon OS, Quinn PA, et al. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study. Clin Sci (Lond) 2011;121:79-89.
16. Meune C, Drexler B, Haaf P, et al. The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide. Heart 2011;97:1479-83.
17. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53. (Pubitemid 350182388)
18. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002;144:981-6. (Pubitemid 36026910)
19. McCann CJ, Glover BM, Menown IB, et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 2008;29:2843-50.
20. Mingels A, Jacobs L, Michielsen E, et al. Reference population and marathon runner sera assessed by Highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-8.
21. Morgenthaler NG, Struck J, Alonso C, et al. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006;52:112-19. (Pubitemid 43032474)
22. Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-61.
23. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
24. Giannitsis E, Kehayova T, Vafaie M, et al. Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction. Clin Chem 2011;57:1452-5.
25. Karakas M, Januzzi JL Jr, Meyer J, et al. Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to Intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study. Clin Chem 2011;57:1137-45.
26. Preibisz JJ, Sealey JE, Laragh JH, et al. Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension 1983;5:I129-38.
27. Robertson GL, Mahr EA, Athar S, et al. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 1973;52:2340-52.
28. Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
29. Omland T, de Lemos JA, Sabatine MS, et al Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361:2538-47.
30. Lippi G, Montagnana M, Guidi GC. The clinical dilemma of positive results of high-sensitive troponin assays. Am J Cardiol 2009;103:1332.
31. Twerenbold R, Reichlin T, Reiter M, et al. High-sensitive cardiac troponin: friend or foe? Swiss Med Wkly 2011;141:w13202.
32. Jaffe AS. The 10 commandments of troponin, with special reference to high sensitivity assays. Heart 2011;97:940e6.
33. Potocki M, Breidthardt T, Mueller A, et al. Copeptin and risk stratification in patients with acute dyspnea. Crit Care 2010;14:R213.
34. Staub D, Morgenthaler NG, Buser C, et al. Use of copeptin in the detection of myocardial ischemia. Clin Chim Acta 2009;399:69-73.
35. Voors AA, von Haehling S, Anker SD, et al. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Eur Heart J 2009;30:1187-94.
36. Hupf H, Grimm D, Riegger GA, et al. Evidence for a vasopressin system in the rat heart. Circ Res 1999;84:365-70. (Pubitemid 29095579)
37. Yoon Y, Song J, Hong SH, et al. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000;46:1626-30.
38. Eggers KM, Lind L, Venge P, et al. Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction? Am J Cardiol 2009;103:588-91.